title: Bisphosphonated benzoxazinorifamycin prodrugs for the prevention and treatment of osteomyelitis.
authors.affiliation: Targanta Therapeutics Inc., 7170 Frederick Banting, 2nd Floor, St. Laurent, QC H4S2A1, Canada.
authors.forename: Ranga
authors.initials: R
authors.lastname: Reddy
authors.forename: Evelyne
authors.initials: E
authors.lastname: Dietrich
authors.forename: Yanick
authors.initials: Y
authors.lastname: Lafontaine
authors.forename: Tom J
authors.initials: TJ
authors.lastname: Houghton
authors.forename: Odette
authors.initials: O
authors.lastname: Belanger
authors.forename: Anik
authors.initials: A
authors.lastname: Dubois
authors.forename: Francis F
authors.initials: FF
authors.lastname: Arhin
authors.forename: Ingrid
authors.initials: I
authors.lastname: Sarmiento
authors.forename: Ibtihal
authors.initials: I
authors.lastname: Fadhil
authors.forename: Karine
authors.initials: K
authors.lastname: Laquerre
authors.forename: Valerie
authors.initials: V
authors.lastname: Ostiguy
authors.forename: Dario
authors.initials: D
authors.lastname: Lehoux
authors.forename: Gregory
authors.initials: G
authors.lastname: Moeck
authors.forename: Thomas R
authors.initials: TR
authors.lastname: Parr
authors.forename: Adel
authors.initials: A
authors.lastname: Rafai Far
mesh_terms: D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry*; D010019:Osteomyelitis / Q000188:drug therapy* / Q000517:prevention & control; D011355:Prodrugs / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry*; D051381:Rats; D012294:Rifamycins / Q000008:administration & dosage / Q000138:chemical synthesis / Q000737:chemistry*; D013211:Staphylococcus aureus / Q000187:drug effects
chemical_list: D000900:Anti-Bacterial Agents; D011355:Prodrugs; D012294:Rifamycins